About GNAS

The GNAS gene (GNAS Complex Locus) on chromosome 20q13 Activating R201 mutations in the GTPase domain occur in pituitary adenomas, fibrous dysplasia, and McCune-Albright syndrome. Key targets include Exons 1–13 for comprehensive mutation screening.

Mutations: R201C, R201H, R844C, GNAS activating | GC content: 51% | Target exons: Exons 1–13

GNAS Primer Design Challenges

  • GTPase hotspot R201: Arginine 201 mutations in exon 8 abolish GTP hydrolysis leading to constitutive cAMP signaling
  • Genomic imprinting: GNAS is maternally imprinted in certain tissues requiring allele-specific primer design for mutation discrimination
  • Balanced GC (51%): Standard PCR conditions suitable, but maternal/paternal allele discrimination requires SNP-linked primer design

Recommended Primer Design Parameters for GNAS

ParameterStandard ExonsOptimized Regions
Primer length20–22 nt22–25 nt
GC content45–55%50–60%
Tm58–62°C60–65°C
Amplicon size150–300 bp180–350 bp
Annealing temp58–60°C60–64°C (touchdown)
PCR additiveStandardOptional 3–5% DMSO for problematic regions

Recommended Primer Sequences for GNAS

Target RegionForward Primer (5′→3′)Reverse Primer (5′→3′)Amplicon
Exon 8 (R201)5′-TGTGAATCCATCATCTTTGC-3′5′-GACAGGTCAGGAGTGGGTTC-3′172 bp
Exon 6 (Gsα domain)5′-GTTGGAGCAGAGGTCAGGAC-3′5′-CACCAAGCCATGACACAGTT-3′184 bp

Key SNPs to Avoid in Primer Binding Sites

When designing GNAS primers, avoid these clinically significant variants:

  • rs121913488 (R201C) — Exon 8 activating mutation in fibrous dysplasia
  • rs121913489 (R201H) — Exon 8 pituitary adenoma hotspot

Clinical Validation Required
All GNAS primers designed with VigyanLLM are for research use only. Clinical diagnostic applications require additional wet-lab validation, Sanger sequencing confirmation, and regulatory approval before patient use.

Design GNAS Primers Now

Pre-configured with GNAS-specific parameters. Use our primer design, Tm calculator, and GC content tools for optimal results.

Design GNAS Primers → Tm Calculator GC Calculator